|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Epistaxis in end stage liver disease masquerading as severe upper gastrointestinal hemorrhage显示文摘AIM:To describe the prevalence,diagnosis,treatment,and outcomes of end stage liver disease(ESLD) patients with severe epistaxis thought to be severe upper gastrointestinal hemorrhage(UGIH).METHODS:This observational single center study included all consecutive patients with ESLD and epistaxis identified from consecutive subjects hospitalized with suspected UGIH and prospectively enrolled in our databases of severe UGIH between 1998 and 2011.RESULTS:A total of 1249 patients were registered for severe UGIH in the data basis,461(36.9%) were cirrhotics. Epistaxis rather than UGIH was the bleeding source in 20 patients. All patients had severe coagulopathy. Epistaxis was initially controlled in all cases. Fifteen(75%) subjects required posterior nasal packing and 2(10%) embolization in addition to correction of coagulopathy. Five(25%) patients died in the hospital,12(60%) received orthotopic liver transplantation(OLT),and 3(15%) were discharged without OLT. The mortality rate was 63% in patients without OLT.CONCLUSION:Severe epistaxis in patients with ESLD is(1) a diagnosis of exclusion that requires upper endoscopy to exclude severe UGIH;and(2) associated with a high mortality rate in patients not receiving OLT. | Marine Camus Dennis M Jensen Jason D Matthews Gordon V Ohning Thomas O Kovacs Rome Jutabha Kevin A Ghassemi Gustavo A Machicado Gareth S Dulai | 2014 | World Journal of Gastroenterology2014，20，38： | 3 |
| 2 | How fish power swimming显示文摘 | ROME L C SWANK D CORDA D | 1993 | Science1993，261，： | 1 |
| 3 | Dual antibiotic loaded bone cement in patients at high infection risks in arthroplasty: Rationale of use for prophylaxis and scientific evidence显示文摘In view of the demographic changes and projected increase of arthroplasty procedures worldwide,the number of prosthetic joint infection cases will naturally grow.Therefore,in order to counteract this trend more rigid rules and a stricter implementation of effective preventive strategies is of highest importance.In the absence of a'miracle weapon'priorities should lie in evidence-based measures including preoperative optimization of patients at higher infection risks,the fulfilment of strict hygiene rules in the operating theatre and an effective antibiotic prophylaxis regimen.Instead of a'one size fits all'philosophy,it has been proposed to adjust the antibiotic prophylaxis protocol to major infection risks taking into account important patient-and procedure-related risk factors.A stronger focus on the local application mode via use of high dose dual antibioticloaded bone cement in such risk situations may have its advantages and is easy to apply in the theatre.The more potent antimicrobial growth inhibition in vitro and the strong reduction of the prosthetic joint infection rate in risk for infection patients with aid of dual antibiotic-loaded bone cement in clinical studies align with this hypothesis. | Christof Ernst Berberich Jérome Josse Frédéric Laurent Tristan Ferry | 2021 | World Journal of Orthopedics2021，12，3： | 1 |
| 4 | How farmers assesssoil health and quality显示文摘 | ROMING D E GARLYND M J HARRIES R F | 1995 | Journal of Soil and Water Conservation1995，50，： | 1 |
| 5 | Diploid/Polyploid Syntenic Shuttle Mapping and Haplotype-Specific Chromosome Walking Toward a Rust Resistance Gene (Bru1) in Highly Polyploid Sugarcane (2n ~ 12x ~ 115)显示文摘 | Le Cunff Lo?c Garsmeur Olivier Raboin Louis Marie Pauquet Jérome Telismart Hugues Selvi Athiappan Grivet Laurent Philippe Romain Begum Dilara Deu Monique Costet Laurent Wing Rod Glaszmann Jean Christophe D’Hont Angélique | 2008 | Genetics2008，，1： | 1 |
| 6 | Aptamer affinity chromatograph: combinatorial chemistry applied to protein purification显示文摘 | ROMING T S BELL C DROLET D W | 1999 | J Chromatogr B1999，731，： | 1 |
| 7 | Increased osteoblast apoptosis in apert craniosynostosis:Role of Protein Kinase C and Interleukin-1显示文摘 | Eric H Philippe D | 2001 | Am J Pathol2001，158，5： | 1 |
| 8 | Expression of the growth arrest-specific gene 6(GAS6)in leukemia and lymphoma cell lines显示文摘 | DIRKS W ROME D RINGEL F | 1999 | Leuk Res1999，23，7： | 1 |
| 9 | Additional structure in infrared excitation spectra of group-Ⅲ acceptors in silicon显示文摘 | FISHER D W ROME J J | 1983 | Phys Rev B1983，27，8： | 1 |
| 10 | Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: A randomized controlled trial显示文摘 | Jean Marc Perarnau Amélie Le Gouge Charlotte Nicolas Louis d’Alteroche Patrick Borentain Faouzi Saliba Anne Minello Rodolphe Anty Carine Chagneau-Derrode Pierre Henri Bernard Armand Abergel Isabelle Ollivier-Hourmand Jérome Gournay Jean Ayoub Christophe G | 2014 | Journal of Hepatology2014，，： | 1 |
| 11 | Creation of a coronary sinus to atrial communicatoion in coronary sinus ostial atresia improves cardiac function after Fontan显示文摘 | Petit C J Webb G D Rome J J | 2007 | Catheter Cardiovasc Interv2007，70，6： | 1 |
| 12 | Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence显示文摘AIM: To identify risk factors associated with survival in patients retransplanted for hepatitis C virus(HCV) recurrence and to apply a survival score to this population.METHODS: We retrospectively identified 108 patients retransplanted for HCV recurrence in eight European liver transplantation centers(seven in France, one in Spain). Data collection comprised clinical and laboratory variables, including virological and antiviral treatment data. We then analyzed the factors associated with survival in this population. A recently published score that predicts survival in retransplantation in patients with hepatitis C was applied. Because there are currently no uniform recommendations regarding selection of the best candidates for retransplantation in this setting, we also described the clinical characteristics of 164 patients not retransplanted, with F3, F4, or fibrosing cholestatic hepatitis(FCH) post-first graft presenting with hepatic decompensation. RESULTS: Overall retransplantation patient survival rates were 55%, 47%, and 43% at 3, 5, and 10 years, respectively. Patients who were retransplanted for advanced cirrhosis had survival rates of 59%, 52%, and 49% at 3, 5, and 10 years, while those retransplanted for FCH had survival rates of 34%, 29%, and 11%, respectively. Under multivariate analysis, and adjusting for the center effect and the occurrence of FCH, factors associated with better survival after retransplantation were: negative HCV viremia before retransplantation, antiviral therapy after retransplantation, non-genotype 1, a Model for End-stage Liver Disease(MELD) score < 25 when replaced on the waiting list, and a retransplantation donor age < 60 years. Although the numbers were small, in the context of the new antivirals era, we showed that outcomes in patientswho underwent retransplantation with undetectable HCV viremia did not depend on donor age and MELD score. The Andrés score was applied to 102 patients for whom all score variables were available, producing a mean score of 43.4(SD = 6.6). Survival rates after the date of the first decompensation post-first liver transplantation(LT1) in the liver retransplantation(re LT) group(94 patients decompensated) at 3, 5, and 10 years were 62%, 59%, and 51%, respectively, among 78 retransplanted individuals with advanced cirrhosis, and 42%, 32%, and 16% among 16 retransplanted individuals with FCH. In the non-re LT group with hepatic decompensation, survival rates were 27%, 18%, and 9% at 3, 5, and 10 years, respectively(P < 0.0001). Compared with non-retransplanted patients, retransplanted patients were younger at LT1(mean age 48 ± 8 years compared to 53 ± 9 years in the no re LT group, P < 0.0001), less likely to have human immunodeficiency virus(HIV) co-infection(4% vs 14% among no re LT patients, P = 0.005), more likely to have received corticosteroid bolus therapy after LT1(25% in re LT vs 12% in the no re LT group, P = 0.01), and more likely to have presented with sustained virological response(SVR) after the first transplantation(20% in the re LT group vs 7% in the no re LT group, P = 0.028).CONCLUSION: Antiviral therapy before and after retransplantation had a substantial impact on survival in the context of retransplantation for HCV recurrence, and with the new direct-acting antivirals now available, outcomes should be even better in the future. | Alice Tung Wan Song Rodolphe Sobesky Carmen Vinaixa Jérome Dumortier Sylvie Radenne Francois Durand Yvon Calmus Géraldine Rousseau Marianne Latournerie Cyrille Feray Valérie Delvart Bruno Roche Stéphanie Haim-Boukobza Anne-Marie Roque-Afonso Denis Castaing Edson Abdala Luiz Augusto Carneiro D’Albuquerque Jean-Charles Duclos-Vallée Marina Berenguer Didier Samuel | 2016 | World Journal of Gastroenterology2016，22，18： | 1 |
| 13 | Functional and biome- chanical characteristics of foot disease in chronic gout: a case- control study显示文摘 | Rome K Survepalli D Sanders A | 2011 | Clin Biomech ( Bristol Avon)2011，26，1： | 1 |
| 14 | Investigation of the sludge reduction mechanism in the anaerobic side-stream reactor process using several control biological wastewater treatment processes显示文摘 | Chon D H Rome M Kim Y M | | 0，，18： | 1 |
| 15 | Generating electricity while walking with loads显示文摘 | Rome L C Flynn L Goldman E M Yon T D | | 0，，5741： | 1 |
| 16 | Phase equilibria of Cu-In system (I): Experimental investigation 显示文摘 | BOLCOVAOE A CHEN S W KAO C R CHANGY A ROMING A D | 1993 | Journal of Phase Equilibria1993，14，： | 1 |
| 17 | Impact of ABO- mismatch on risk of GVHD after umbilical cord blood transplantation 显示文摘 | Romee R Weisdorf D J Brunstein C | 2013 | Bone Marrow Transplant2013，48，8： | 1 |
| 18 | Investigtion of the sludge reduction mechanism in anaerobic side-stream reactor process using several control biological wastewater treatment processes显示文摘 | Chon D H Rome M Kim Y M | 2011 | Water Research2011，45，18： | 1 |
| 19 | Expected and unexpected adverse effects H1N1 vaccination for health care workers in a university hospital显示文摘 | Aurélien D Christine L Jérome S | | 0，，： | 1 |
| 20 | Investigation of the sludge reduction mechanism in the anaerobic side-stream reactor process using several control biological wastewater treatment processes 显示文摘 | Chon D H Rome M Kim Y M | 2011 | Water Research2011，45，18： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员